ITC’s alignment with healthcare’s a global trend it needs to deepen
Synopsis
ITC’s shares gained 1.5% Thursday on the back of the company conducting clinical trials for developing a nasal spray for Covid-19 prevention. It plans to market the nasal spray under the Savlon brand once it gets all the requisite approvals. Investors cheered the move even though it is still early stage for the company.
ET Intelligence Group: ITC’s shares gained 1.5% Thursday on the back of the company conducting clinical trials for developing a nasal spray for Covid-19 prevention. It plans to market the nasal spray under the Savlon brand once it gets all the requisite approvals. Investors cheered the move even though it is still early stage for the company.
For a business conglomerate facing the heat for selling cigarettes to align with the goal of
- FONT SIZE
AbcSmall
AbcMedium
AbcLarge
Sign in to read the full article
You’ve got this Prime Story as a Free Gift
₹399/month
Monthly
PLAN
Billed Amount ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Amount ₹2,499
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-Year
PLAN
Billed Amount ₹3,599
15
Days Trial
+Includes DocuBay and TimesPrime Membership.
Already a Member? Sign In now
Get Offer
Why ?
-
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
-
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
-
Clean experience with
Minimal Ads -
Comment & Engage with ET Prime community -
Exclusive invites to Virtual Events with Industry Leaders -
A trusted team of Journalists & Analysts who can best filter signal from noise
Stay connected with us on social media platform for instant update click here to join our Twitter, & Facebook
We are now on Telegram. Click here to join our channel (@TechiUpdate) and stay updated with the latest Technology headlines.
For all the latest Education News Click Here
For the latest news and updates, follow us on Google News.